Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States

Background: Hepatitis C (HCV) direct acting antiviral agents (DAAs) are safe, effective, and tolerable. Most contraindications to interferon-based treatment are no long applicable. The aims of this study were to understand the predictors of approval to drug accessibility. Methods: We studied all con...

Descripción completa

Detalles Bibliográficos
Autores principales: Saab, Sammy, Jimenez, Melissa, Fong, Tiffany, Wu, Crystal, Bau, Sherona, Jamal, Zoha, Grotts, Jonathan, Elashoff, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913077/
https://www.ncbi.nlm.nih.gov/pubmed/27350937
http://dx.doi.org/10.14218/JCTH.2016.00011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913077/
https://www.ncbi.nlm.nih.gov/pubmed/27350937
http://dx.doi.org/10.14218/JCTH.2016.00011

Ejemplares similares